Harsing; Laszlo Gabor

Patent Applications and Registrations

Patent applications and USPTO patent grants for Harsing; Laszlo Gabor.The latest application filed is for "2,3,4-benzothiadiazepine-2,2-dioxide derivatives".

Company Profile

0.6.17

Harsing; Laszlo Gabor - Budapest HU
Harsing; Laszlo Gabor - Budagpest HU

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Medicament for the enhancement of cognitive function and neuroprotection Grant 8,318,743 - Gacsalyi , et al. November 27, 2	2012-11-27
2,3,4-benzothiadiazepine-2,2-dioxide Derivatives App 20120252784 - FETTER; Jozsef ; et al.	2012-10-04
Optically Active 3-[(phenylpiperazin-1-yl)alkyl]-3- Alkyl-oxindole Derivatives Having Cns Activity App 20120108607 - Volk; Balazs ; et al.	2012-05-03
8-chloro-2,3-benzodiazepine derivatives Grant 7,960,375 - Barkoczy , et al. June 14, 2	2011-06-14
Piperazine derivatives of alkyl oxindoles Grant 7,910,591 - Volk , et al. March 22, 2	2011-03-22
Piperazine derivatives of dialkyl oxindoles Grant 7,786,129 - Volk , et al. August 31, 2	2010-08-31
3,4-dihydrobenzo[1,2,3]thiadiazine-1,1-dioxide Derivatives, Process For Preparation Thereof, Medicaments Containing Said Derivatives And Their Use App 20100190778 - Porcs-Makkay; Marta ; et al.	2010-07-29
Benzo[1,2,3]thiadiazine Derivates App 20100168087 - Porcs-Makkay; Marta ; et al.	2010-07-01
Medicament For The Enhancement Of Cognitive Function And Neuroprotection App 20100075975 - Gacsalyi; Istvan ; et al.	2010-03-25
Indol-2-one Derivatives For The Treatment Of Central Nervous Disorders, Gastrointestinal Disorders And Cardiovascular Disorders App 20090281137 - Volk; Balazs ; et al.	2009-11-12
Optical Isomers Of Dihydro-2,3-benzodiazepines And Their Stereoselective Synthesis App 20090233913 - Ling; Istvan ; et al.	2009-09-17
Piperazine Derivatives of Alkyl Oxindoles App 20080161323 - Volk; Balazs ; et al.	2008-07-03
Combined Pharmaceutical Composition for the Inhibition of the Decline of Cognitive Functions App 20080021016 - Levay; Gyorgy ; et al.	2008-01-24
Pyridine Derivatives of Alkyl Oxindoles as 5-Ht7 Receptor Active Agents App 20070265300 - Volk; Balazs ; et al.	2007-11-15
Combination of Dermaciclane and Opoids as Analgesics App 20070244102 - Gacsalyi; Istvan ; et al.	2007-10-18
Indol-2-One Derivatives for the Treatment of Central Nervous Disorders, Gastrointestinal Disorders and Cardiovascular Disorders App 20070232662 - Volk; Balazs ; et al.	2007-10-04
Piperazine Derivatives of Dialkyl Oxindoles App 20070232619 - Volk; Balazs ; et al.	2007-10-04
Piperazine Derivatives Of Alkyl Oxindoles App 20070219209 - Volk; Balazs ; et al.	2007-09-20
2, 3-benzodiazepine derivatives and pharmaceutical compositions containing the same as the active ingredient Grant 7,189,711 - Ling , et al. March 13, 2	2007-03-13
Piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds Grant 7,183,283 - Barkoczy , et al. February 27, 2	2007-02-27
Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions App 20060211703 - Levay; Gyorgy ; et al.	2006-09-21
Piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds App 20050215560 - Barkoczy, Jozsef ; et al.	2005-09-29
Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions App 20040171696 - Gacsalyi, Istvan ; et al.	2004-09-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.